These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9727784)

  • 1. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.
    Plit ML; Anderson R; Van Rensburg CE; Page-Shipp L; Blott JA; Fresen JL; Feldman C
    Eur Respir J; 1998 Aug; 12(2):351-6. PubMed ID: 9727784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-tuberculous lung function impairment in a tuberculosis reference clinic in Cameroon.
    Mbatchou Ngahane BH; Nouyep J; Nganda Motto M; Mapoure Njankouo Y; Wandji A; Endale M; Afane Ze E
    Respir Med; 2016 May; 114():67-71. PubMed ID: 27109813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis.
    Plit ML; Theron AJ; Fickl H; van Rensburg CE; Pendel S; Anderson R
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):590-6. PubMed ID: 9661828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical characteristics of different types of lung function impaiement in TDL patients.
    Zhao J; Cao X; Li Y; Li Y; Ma T; Liu F; Ruan H
    BMC Pulm Med; 2024 Jun; 24(1):292. PubMed ID: 38914991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis.
    Auld SC; Kornfeld H; Maenetje P; Mlotshwa M; Chase W; Vangu MD; Torigian DA; Wallis RS; Churchyard G; Bisson GP
    BMC Pulm Med; 2021 Jan; 21(1):19. PubMed ID: 33413293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis.
    de Vallière S; Barker RD
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):767-71. PubMed ID: 15182148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel scoring system to measure radiographic abnormalities and related spirometric values in cured pulmonary tuberculosis.
    Báez-Saldaña R; López-Arteaga Y; Bizarrón-Muro A; Ferreira-Guerrero E; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Mongua-Rodríguez N; García-García L
    PLoS One; 2013; 8(11):e78926. PubMed ID: 24223865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of chronic lung impairment in Mozambican TB patients and associated risks.
    Khosa C; Bhatt N; Massango I; Azam K; Saathoff E; Bakuli A; Riess F; Ivanova O; Hoelscher M; Rachow A
    BMC Pulm Med; 2020 May; 20(1):127. PubMed ID: 32381002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary impairment after tuberculosis.
    Pasipanodya JG; Miller TL; Vecino M; Munguia G; Garmon R; Bae S; Drewyer G; Weis SE
    Chest; 2007 Jun; 131(6):1817-24. PubMed ID: 17400690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
    Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary functions' assessment in post-tuberculosis cases by spirometry: Obstructive pattern is predominant and needs cautious evaluation in all treated cases irrespective of symptoms.
    Patil S; Patil R; Jadhav A
    Int J Mycobacteriol; 2018; 7(2):128-133. PubMed ID: 29900887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Respiratory functional changes in pulmonary tuberculosis].
    Apostu M; Mihăescu T
    Pneumologia; 2013; 62(3):148-57. PubMed ID: 24273998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamics of changes in lung function in patients with recurrent tuberculosis and ineffective primary treatment in intensive phase of controlled chemotherapy].
    Nefedov VB; Popova LA; Shergina EA
    Probl Tuberk; 2002; (12):29-32. PubMed ID: 12611332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012.
    Jung JW; Choi JC; Shin JW; Kim JY; Choi BW; Park IW
    PLoS One; 2015; 10(10):e0141230. PubMed ID: 26496500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study.
    Nightingale R; Chinoko B; Lesosky M; Rylance SJ; Mnesa B; Banda NPK; Joekes E; Squire SB; Mortimer K; Meghji J; Rylance J
    Thorax; 2022 Nov; 77(11):1131-1139. PubMed ID: 34937802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.